Groupe la Francaise »

Terns Pharmaceuticals shares owned by Groupe la Francaise

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Groupe la Francaise from 13F filings

Historical chart of Groupe la Francaise investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Groupe la Francaise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Groupe la Francaise

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.2M 118k 52.72

More positions owned by Groupe la Francaise

Totalenergies Se Act (TTE)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Astrazeneca Ord (AZN)
JPMorgan Chase & Co. (JPM)
Cgi Cl A Sub Vtg (GIB)
Visa Com Cl A (V)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Ferrari Nv Ord (RACE)
Meta Platforms Cl A (META)

View all positions for Groupe la Francaise

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals